Biolife Solutions (BLFS) Other Operating Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Other Operating Expenses data on file, last reported at $2.6 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $2.6 million, up 4.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.8 million (up 585.95% YoY), and the FY2025 annual result was $25.6 million, up 178.78% from the prior year.
• Other Operating Expenses climbed to $2.6 million in Q1 2026 per BLFS's latest filing, from -$27.1 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $102.0 million in Q2 2022 and troughed at -$127.8 million in Q4 2022.
• A 5-year average of $5.3 million and a median of $10.6 million in 2024 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 5522.63% in 2022 and fell as far as 508.96% in 2022.
• A 5-year view of Other Operating Expenses shows it stood at -$127.8 million in 2022, then jumped by 54.48% to -$58.2 million in 2023, then surged by 65.06% to -$20.3 million in 2024, then slumped by 33.54% to -$27.1 million in 2025, then soared by 109.62% to $2.6 million in 2026.
• Business Quant data shows BLFS's Other Operating Expenses at $2.6 million in Q1 2026, -$27.1 million in Q4 2025, and $13.4 million in Q3 2025.